Wer ihnen entgehen will, soll Werke in den USA bauen. Einfach wird das nicht.

Trump hat die Pharmabranche im Ausland im Visier. Er will, dass Medikamente in den USA produziert werden. Sein Druckmittel: Zölle.

US President Donald Trump on Tuesday announced a phased tariff regime on imported generic medicines, saying they will continue to enter the United States duty-free for two years…

Trump has been pressuring drugmakers through his most-favored-nation drug pricing policy to lower prices to what people pay in other high-income countries.

President Donald Trump has given generic drugmakers two years to shift manufacturing to the US or face 100% import tariffs from August 2028, rising to 200% a year later. The move…